Works matching IS 00778923 AND DT 2012 AND VI 1263 AND IP 1
Results: 4
Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives - an update.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1263, n. 1, p. 1, doi. 10.1111/j.1749-6632.2012.06670.x
- By:
- Publication type:
- Article
The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1263, n. 1, p. 29, doi. 10.1111/j.1749-6632.2012.06674.x
- By:
- Publication type:
- Article
Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM<sub>197</sub> conjugate vaccine.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1263, n. 1, p. 15, doi. 10.1111/j.1749-6632.2012.06673.x
- By:
- Publication type:
- Article
Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1263, n. 1, p. 43, doi. 10.1111/j.1749-6632.2012.06661.x
- By:
- Publication type:
- Article